Hepatitis C is a contagious disease of the liver which is caused by the hepatitis C virus (HCV). Most become infected by direct contact with blood from a patient who is already infected through the sharing of needles or sometimes from sexual contact. It is estimated 3.4 million Americans have chronic hepatitis C. Hepatitis C can become a chronic infection that will lead to liver cancer.
Some of the symptoms of hepatitis C are loss of appetite, nausea, abdominal pain, fatigue and joint pain all of which cannabinoids can help reduce in multiple product types from extracted oil, vaporizing and medible formats.
Based on a recent research study cannabinoids helped improve the effectiveness of various types of drug therapy for hepatitis C. It also showed that smoking cannabinoids made it more effective in reaching the objective of a sustained virological response which is considered a huge success with the disease not being found anywhere in the body.